Knowledge Distillery

The novel SARS-CoV-2 Omicron variant (B.1.1.529), first found in early November 2021, has sparked considerable global concern and it has >50…

Emergence of SARS-CoV-2 variants of concern (VOCs) suggests viral adaptation to enhance human-to-human transmission. Although much effort has focused…

The SARS-CoV-2 B.1.1.529 variant (Omicron) contains 15 mutations on the receptor-binding domain (RBD). How Omicron would evade RBD neutralizing…

People with COVID-19 might have sustained postinfection sequelae. Known by a variety of names, including long COVID or long-haul COVID, and listed in…

Recent studies suggested that anti-CD20 and fingolimod may be associated with lower anti-spike protein-based immunoglobulin-G response following…

Vaccines have represented the breakthrough in the fight against COVID-19. Based on reported headache attacks after vaccination in randomized…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) is frequently more severe in individuals with preexisting respiratory and…

Data on interruption of enzyme replacement therapy are scarce in late-onset Pompe disease. Due to the COVID-19 crisis, 8 neuromuscular reference…

The objective of this study was to descriptive analysis of COVID-19 infection in patients with multiple sclerosis (MS) receiving fingolimod or…

At present, delta variant is estimated to have caused more than 99% of COVID-19 infections worldwide; however, a new variant of concern, omicron…

The objective of this test negative case-control study was to evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 variants and…

To estimate the growth of the Omicron variant of concern and its immune escape characteristics, the authors analysed data from all PCR-confirmed…